Evaluation of the Effect of an Specific Oral Nutritional Supplement on the Nutritional Status in Cancer and Malnutrition

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

August 1, 2020

Study Completion Date

August 1, 2020

Conditions
MalnutritionCancerNutrition Related Cancer
Interventions
DIETARY_SUPPLEMENT

Experimental Group

Nutritional intervention and physical activity recommendations. Consumption of 2 tetra paks/day of a specific oral nutritional supplement (hypercaloric/hyperproteic with fiber and omega-3 enriched, with L-leucine, betaglucans and medium chain triglycerides) for 8 weeks.

DIETARY_SUPPLEMENT

Control Group

Nutritional intervention and physical activity recommendations. Consumption of 2 tetra paks/day of a specific oral nutritional supplement (hypercaloric/hyperproteic with fiber) for 8 weeks.

Trial Locations (1)

28046

Institute for Health Research IdiPAZ, Madrid

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Adventia Pharma

INDUSTRY

lead

Instituto de Investigación Hospital Universitario La Paz

OTHER

NCT04184713 - Evaluation of the Effect of an Specific Oral Nutritional Supplement on the Nutritional Status in Cancer and Malnutrition | Biotech Hunter | Biotech Hunter